Zalicus Inc. (ZLCS)


Zalicus Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. Zalicus applies its selective ion-channel modulation platform and its combination high throughput screening capabilities to discover innovative therapeutics for itself and its collaborators.

Contact Information

245 First Street
Third Floor
Cambridge, MA 02142

tel: 617-301-7000
fax: 617-301-7010


Investor Relations

Senior VP & CFO, Zalicus Inc.
Justin Renz
tel: 617-301-7575


Exchange: NASDAQ
Industry: Biotechnology
Market Cap: $122.5M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.